Clinical Trial Update: An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C) [Phase 3]

View source ↗

Summary

An extension study (IMbrella C) for participants previously enrolled in Genentech/Roche-sponsored atezolizumab trials (IMbrella C), Phase 3. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Tecentriq (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neoplasms | Phase 3 | Status: ACTIVE_NOT_RECRUITING